These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 34395250)

  • 1. Bioinformatics Analysis and Functional Verification of ADAMTS9-AS1/AS2 in Lung Adenocarcinoma.
    Liu W; Luo W; Zhou P; Cheng Y; Qian L
    Front Oncol; 2021; 11():681777. PubMed ID: 34395250
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Construction of a Competitive Endogenous RNA Network and Identification of Potential Regulatory Axis in Gastric Cancer.
    Pan H; Guo C; Pan J; Guo D; Song S; Zhou Y; Xu D
    Front Oncol; 2019; 9():912. PubMed ID: 31637209
    [No Abstract]   [Full Text] [Related]  

  • 3. LncRNA ADAMTS9-AS2 is a Prognostic Biomarker and Correlated with Immune Infiltrates in Lung Adenocarcinoma.
    Lin Z; Huang W; Yi Y; Li D; Xie Z; Li Z; Ye M
    Int J Gen Med; 2021; 14():8541-8555. PubMed ID: 34849000
    [TBL] [Abstract][Full Text] [Related]  

  • 4. lncRNA ADAMTS9-AS2 Controls Human Mesenchymal Stem Cell Chondrogenic Differentiation and Functions as a ceRNA.
    Huang MJ; Zhao JY; Xu JJ; Li J; Zhuang YF; Zhang XL
    Mol Ther Nucleic Acids; 2019 Dec; 18():533-545. PubMed ID: 31671346
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Data Mining and Expression Analysis of Differential lncRNA ADAMTS9-AS1 in Prostate Cancer.
    Wan J; Jiang S; Jiang Y; Ma W; Wang X; He Z; Wang X; Cui R
    Front Genet; 2019; 10():1377. PubMed ID: 32153626
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LncRNA ADAMTS9-AS1 inhibits the stemness of lung adenocarcinoma cells by regulating miR-5009-3p/NPNT axis.
    Wang P; Zhang Y; Lv X; Zhou J; Cang S; Song Y
    Genomics; 2023 May; 115(3):110596. PubMed ID: 36870548
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LncRNA ADAMTS9-AS2 regulates ovarian cancer progression by targeting miR-182-5p/FOXF2 signaling pathway.
    Wang A; Jin C; Li H; Qin Q; Li L
    Int J Biol Macromol; 2018 Dec; 120(Pt B):1705-1713. PubMed ID: 30268751
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LncRNA MIR155HG functions as a ceRNA for inhibition of lung adenocarcinoma growth and prediction of prognosis.
    Wang J; Li J
    Arch Med Sci; 2024; 20(2):539-556. PubMed ID: 38757039
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of key genes in lung adenocarcinoma based on a competing endogenous RNA network.
    Song Z; Zhang Y; Chen Z; Zhang B
    Oncol Lett; 2021 Jan; 21(1):60. PubMed ID: 33281971
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Upregulated lncRNA ADAMTS9-AS2 suppresses progression of lung cancer through inhibition of miR-223-3p and promotion of TGFBR3.
    Liu C; Yang Z; Deng Z; Zhou Y; Gong Q; Zhao R; Chen T
    IUBMB Life; 2018 Jun; 70(6):536-546. PubMed ID: 29707897
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long non-coding RNA ADAMTS9-AS1 suppresses colorectal cancer by inhibiting the Wnt/β-catenin signalling pathway and is a potential diagnostic biomarker.
    Li N; Li J; Mi Q; Xie Y; Li P; Wang L; Binang H; Wang Q; Wang Y; Chen Y; Wang Y; Mao H; Du L; Wang C
    J Cell Mol Med; 2020 Oct; 24(19):11318-11329. PubMed ID: 32889785
    [TBL] [Abstract][Full Text] [Related]  

  • 12. lncRNA ADAMTS9-AS1/circFN1 Competitively Binds to miR-206 to Elevate the Expression of ACTB, Thus Inducing Hypertrophic Cardiomyopathy.
    Feng W; Han S
    Oxid Med Cell Longev; 2022; 2022():1450610. PubMed ID: 35401927
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of long noncoding RNAs downregulated specifically in ovarian high-grade serous carcinoma.
    Hayashi-Okada M; Sato S; Nakashima K; Sakai T; Tamehisa T; Kajimura T; Tamura I; Sueoka K; Sugino N
    Reprod Med Biol; 2024; 23(1):e12572. PubMed ID: 38571514
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LncRNA ADAMTS9-AS2 promotes tongue squamous cell carcinoma proliferation, migration and EMT via the miR-600/EZH2 axis.
    Li Y; Wan Q; Wang W; Mai L; Sha L; Mashrah M; Lin Z; Pan C
    Biomed Pharmacother; 2019 Apr; 112():108719. PubMed ID: 30970517
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exosome-derived long non-coding RNA ADAMTS9-AS2 suppresses progression of oral submucous fibrosis via AKT signalling pathway.
    Zhou S; Zhu Y; Li Z; Zhu Y; He Z; Zhang C
    J Cell Mol Med; 2021 Feb; 25(4):2262-2273. PubMed ID: 33345447
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictions of the dysregulated competing endogenous RNA signature involved in the progression of human lung adenocarcinoma.
    Yang D; He Y; Wu B; Liu R; Wang N; Wang T; Luo Y; Li Y; Liu Y
    Cancer Biomark; 2020; 29(3):399-416. PubMed ID: 32741804
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The lncRNA ADAMTS9-AS2 Regulates RPL22 to Modulate TNBC Progression
    Ni K; Huang Z; Zhu Y; Xue D; Jin Q; Zhang C; Gu C
    Front Oncol; 2021; 11():654472. PubMed ID: 34178640
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bioinformatics Analysis of the Expression of Key Long Intergenic Non-Protein Coding RNA Genes in Bladder Cancer.
    Lin YZ; Wu YP; Ke ZB; Cai H; Chen DN; Chen SH; Li XD; Lin TT; Huang JB; Zheng QS; Xue XY; Xu N; Wei Y
    Med Sci Monit; 2020 Apr; 26():e920504. PubMed ID: 32277695
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Upregulation of lncRNA ADAMTS9-AS2 Promotes Salivary Adenoid Cystic Carcinoma Metastasis via PI3K/Akt and MEK/Erk Signaling.
    Xie S; Yu X; Li Y; Ma H; Fan S; Chen W; Pan G; Wang W; Zhang H; Li J; Lin Z
    Mol Ther; 2018 Dec; 26(12):2766-2778. PubMed ID: 30217729
    [TBL] [Abstract][Full Text] [Related]  

  • 20. M6A Promotes Colorectal Cancer Progression via Regulating the miR-27a-3p/BTG2 Pathway.
    Liu W; Zhang Z; Luo X; Qian K; Huang B; Deng J; Yang C
    J Oncol; 2023; 2023():7097909. PubMed ID: 36816363
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.